As shares of Moderna and Merck surge on new vaccine trial data, we speak to a top analyst about why he thinks the move higher is very difficult to rationalize. Then, Former CEA Chair Jason Furman discusses the Treasury Department's new debt buyback operations. Plus, we bring you the details of Chinese robotics company Unitree soaring in its public debut in Shanghai.
Podden och tillhörande omslagsbild på den här sidan tillhör
CNBC. Innehållet i podden är skapat av CNBC och inte av,
eller tillsammans med, Poddtoppen.
